GRIFOLS SA-ADR (GRFS) Stock Fundamental Analysis

NASDAQ:GRFS • US3984384087

9.44 USD
-0.28 (-2.88%)
Last: Feb 19, 2026, 08:05 PM
Fundamental Rating

6

Overall GRFS gets a fundamental rating of 6 out of 10. We evaluated GRFS against 521 industry peers in the Biotechnology industry. While GRFS has a great profitability rating, there are some minor concerns on its financial health. GRFS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • GRFS had positive earnings in the past year.
  • GRFS had a positive operating cash flow in the past year.
  • Each year in the past 5 years GRFS has been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: GRFS reported negative operating cash flow in multiple years.
GRFS Yearly Net Income VS EBIT VS OCF VS FCFGRFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

1.2 Ratios

  • GRFS has a Return On Assets of 1.88%. This is amongst the best in the industry. GRFS outperforms 88.68% of its industry peers.
  • With an excellent Return On Equity value of 7.20%, GRFS belongs to the best of the industry, outperforming 91.17% of the companies in the same industry.
  • The Return On Invested Capital of GRFS (4.93%) is better than 91.55% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GRFS is significantly below the industry average of 18.69%.
  • The 3 year average ROIC (2.90%) for GRFS is below the current ROIC(4.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.88%
ROE 7.2%
ROIC 4.93%
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
GRFS Yearly ROA, ROE, ROICGRFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • GRFS's Profit Margin of 4.96% is amongst the best of the industry. GRFS outperforms 89.06% of its industry peers.
  • GRFS's Profit Margin has declined in the last couple of years.
  • GRFS has a better Operating Margin (18.06%) than 94.05% of its industry peers.
  • In the last couple of years the Operating Margin of GRFS has declined.
  • GRFS has a Gross Margin of 39.09%. This is in the better half of the industry: GRFS outperforms 73.90% of its industry peers.
  • GRFS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.06%
PM (TTM) 4.96%
GM 39.09%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
GRFS Yearly Profit, Operating, Gross MarginsGRFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GRFS is destroying value.
  • GRFS has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GRFS remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for GRFS has been reduced compared to a year ago.
GRFS Yearly Shares OutstandingGRFS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GRFS Yearly Total Debt VS Total AssetsGRFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • GRFS has an Altman-Z score of 1.34. This is a bad value and indicates that GRFS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.34, GRFS is in the better half of the industry, outperforming 64.49% of the companies in the same industry.
  • The Debt to FCF ratio of GRFS is 13.86, which is on the high side as it means it would take GRFS, 13.86 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 13.86, GRFS belongs to the top of the industry, outperforming 90.21% of the companies in the same industry.
  • A Debt/Equity ratio of 1.76 is on the high side and indicates that GRFS has dependencies on debt financing.
  • The Debt to Equity ratio of GRFS (1.76) is worse than 77.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF 13.86
Altman-Z 1.34
ROIC/WACC0.95
WACC5.19%
GRFS Yearly LT Debt VS Equity VS FCFGRFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • GRFS has a Current Ratio of 2.48. This indicates that GRFS is financially healthy and has no problem in meeting its short term obligations.
  • GRFS has a worse Current ratio (2.48) than 70.44% of its industry peers.
  • A Quick Ratio of 0.93 indicates that GRFS may have some problems paying its short term obligations.
  • GRFS has a Quick ratio of 0.93. This is amonst the worse of the industry: GRFS underperforms 85.41% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 0.93
GRFS Yearly Current Assets VS Current LiabilitesGRFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

  • GRFS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 160.05%, which is quite impressive.
  • The earnings per share for GRFS have been decreasing by -23.99% on average. This is quite bad
  • Looking at the last year, GRFS shows a small growth in Revenue. The Revenue has grown by 7.31% in the last year.
  • The Revenue has been growing slightly by 7.18% on average over the past years.
EPS 1Y (TTM)160.05%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%133.5%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%4.04%

3.2 Future

  • GRFS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.98% yearly.
  • The Revenue is expected to grow by 5.47% on average over the next years.
EPS Next Y40.91%
EPS Next 2Y33.09%
EPS Next 3Y30.53%
EPS Next 5Y21.98%
Revenue Next Year5.37%
Revenue Next 2Y5.26%
Revenue Next 3Y5.69%
Revenue Next 5Y5.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GRFS Yearly Revenue VS EstimatesGRFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
GRFS Yearly EPS VS EstimatesGRFS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

9

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.52, the valuation of GRFS can be described as correct.
  • 96.35% of the companies in the same industry are more expensive than GRFS, based on the Price/Earnings ratio.
  • GRFS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.09.
  • A Price/Forward Earnings ratio of 8.19 indicates a reasonable valuation of GRFS.
  • Based on the Price/Forward Earnings ratio, GRFS is valued cheaply inside the industry as 98.46% of the companies are valued more expensively.
  • GRFS is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.52
Fwd PE 8.19
GRFS Price Earnings VS Forward Price EarningsGRFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GRFS is valued cheaper than 98.27% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GRFS is valued cheaper than 99.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.76
EV/EBITDA 7.96
GRFS Per share dataGRFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • GRFS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GRFS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as GRFS's earnings are expected to grow with 30.53% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y33.09%
EPS Next 3Y30.53%

6

5. Dividend

5.1 Amount

  • GRFS has a Yearly Dividend Yield of 4.44%, which is a nice return.
  • GRFS's Dividend Yield is rather good when compared to the industry average which is at 1.17. GRFS pays more dividend than 99.23% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, GRFS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.44%

5.2 History

  • The dividend of GRFS decreases each year by -66.87%.
  • GRFS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-66.87%
Div Incr Years0
Div Non Decr Years0
GRFS Yearly Dividends per shareGRFS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • GRFS pays out 27.73% of its income as dividend. This is a sustainable payout ratio.
DP27.73%
EPS Next 2Y33.09%
EPS Next 3Y30.53%
GRFS Yearly Income VS Free CF VS DividendGRFS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M
GRFS Dividend Payout.GRFS Dividend Payout, showing the Payout Ratio.GRFS Dividend Payout.PayoutRetained Earnings

GRIFOLS SA-ADR

NASDAQ:GRFS (2/19/2026, 8:05:03 PM)

9.44

-0.28 (-2.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)02-26
Inst Owners31.55%
Inst Owner Change-0.18%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap6.42B
Revenue(TTM)7.52B
Net Income(TTM)372.72M
Analysts77.14
Price Target13.65 (44.6%)
Short Float %2.43%
Short Ratio14.69
Dividend
Industry RankSector Rank
Dividend Yield 4.44%
Yearly Dividend0
Dividend Growth(5Y)-66.87%
DP27.73%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.03%
PT rev (3m)3.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.29%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 14.52
Fwd PE 8.19
P/S 0.72
P/FCF 7.76
P/OCF 4.8
P/B 1.05
P/tB N/A
EV/EBITDA 7.96
EPS(TTM)0.65
EY6.89%
EPS(NY)1.15
Fwd EY12.21%
FCF(TTM)1.22
FCFY12.89%
OCF(TTM)1.97
OCFY20.85%
SpS13.09
BVpS9.01
TBVpS-9.29
PEG (NY)0.35
PEG (5Y)N/A
Graham Number11.48
Profitability
Industry RankSector Rank
ROA 1.88%
ROE 7.2%
ROCE 7.67%
ROIC 4.93%
ROICexc 5.17%
ROICexgc 13.72%
OM 18.06%
PM (TTM) 4.96%
GM 39.09%
FCFM 9.3%
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
ROICexc(3y)3.07%
ROICexc(5y)3.33%
ROICexgc(3y)6.89%
ROICexgc(5y)7.47%
ROCE(3y)4.51%
ROCE(5y)4.82%
ROICexgc growth 3Y11.6%
ROICexgc growth 5Y-8.62%
ROICexc growth 3Y14.21%
ROICexc growth 5Y-7.74%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
F-Score7
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF 13.86
Debt/EBITDA 5.08
Cap/Depr 99.96%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 63.19%
Profit Quality 187.58%
Current Ratio 2.48
Quick Ratio 0.93
Altman-Z 1.34
F-Score7
WACC5.19%
ROIC/WACC0.95
Cap/Depr(3y)62.1%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.39%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)160.05%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%133.5%
EPS Next Y40.91%
EPS Next 2Y33.09%
EPS Next 3Y30.53%
EPS Next 5Y21.98%
Revenue 1Y (TTM)7.31%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%4.04%
Revenue Next Year5.37%
Revenue Next 2Y5.26%
Revenue Next 3Y5.69%
Revenue Next 5Y5.47%
EBIT growth 1Y35.86%
EBIT growth 3Y27.11%
EBIT growth 5Y0.58%
EBIT Next Year44.75%
EBIT Next 3Y20.41%
EBIT Next 5Y16.88%
FCF growth 1Y-79.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-168.33%
OCF growth 3YN/A
OCF growth 5YN/A

GRIFOLS SA-ADR / GRFS FAQ

Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to GRFS.


What is the valuation status of GRIFOLS SA-ADR (GRFS) stock?

ChartMill assigns a valuation rating of 9 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.


What is the profitability of GRFS stock?

GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GRFS stock?

The Price/Earnings (PE) ratio for GRIFOLS SA-ADR (GRFS) is 14.52 and the Price/Book (PB) ratio is 1.05.


What is the financial health of GRIFOLS SA-ADR (GRFS) stock?

The financial health rating of GRIFOLS SA-ADR (GRFS) is 4 / 10.